DAFTAR PUSTAKA

1. Maryunani A., Yulianingsih. 2009. Asuhan Kegawat daruratan Dalam

Kebidanan.Jakarta : CV Trans Info Media.

2. Manuaba, I.B.G. 2010. Ilmu Kebidanan, Penyakit Kandungan dan

KB.Jakarta : ECG.

3. Angsar, D.M. 2009. Hipertesi Dalam Kehamilan. Dalam Sarwono

Prawiroharjo “Ilmu Kebidanan”, Edisi 4. Jakarta : PT Bina Pustaka
Sarwono Prawiroharjo.

4. Rini S.C. 2010. Penatalaksanaan Terapi Pasien Preeklampia Rawat

Inap RSUP Dr. Soeradji Tirtonegoro Klaten Tahun 2009. Fakultas
Farmasi Universitas Muhammadiyah Surakarta.

5. Boyce T, Dodd C, Waugh J. Hypertensive Disorder. In: Robson SE,

Waugh J, editors. Medical Disorder in Pregnancy: a manual for
midwives [e-book]: Blackwell Publishing Ltd; 2008.

6. Varney H. Buku Ajar Asuhan Kebidanan. 3 ed. Jakarta: Penerbit Buku

Kedokteran EGC; 2007.

7. WHO recommmendations for Prevention and treatment of pre-

clampsiaanf eclampsia. WHO Handbook for guideline development
[Internet]. 2016. Available from:
http://whqlibdoc.who.int/hq/2011/WHO_RHR_11.30_eng.pdf.

8. Himpunan Kedokteran Feto Maternal; Pedoman pengelolaan

hipertensi dalam kehamilan di Indonesia. Edisi 2. Batam:2005.

9. Cunningham FG, Leveno K, Bloom S, Hauth J, Rouse D, Spong C.

William Obstetrics : 23rd Edition: MacGraw Hill Professional; 2009.

10. Wylie L, Bryce H. The Midwives’ Guide to Key Medical Conditions

Pregnancy and Childbirth. Edinburgh: Churchill Livingstone; 2008.

11. Powe CE, Levine RJ, Karumanchi SA. Preeclampsia, a disease of the
maternal endothelium: The role of antiangiogenic factors and
implications for later cardiovascular disease. Circulation
2011;123:2856-69.

12. Bilano VL, Ota E, Ganchimeg T, Mori R, Souza JP. Risk Factor of Pre-
Eclampsia and its adverse outcomes in low- and middle income

59
 60

countries : a WHO secondary analysis. PLOS one. 2014;9(3). Epub

March 2014.

13. Mikat B, Gellhaus A, Wagner N, Birdir C, Kimming R, Koninger A.

Review Article, Early detection of maternal risk for preeclampsia.
International Scholarly Research Network (ISRN) Obstetric and
Gynecology [Internet]. 2012.

14. Payne BA, Hutcheon JA, Ansermino M, Hall DR, Bhutta ZA, Bhutta SZ,
et al. A risk prediction model for the assessment and triage of women
with hipertensive disorder of pregnancy in low-resourched setting: the
miniPIERS (Pre-eclampsia Integrated Estimate of RiSk) multi-country
prospective cohorthsttudy. PLOS Medicine. 2014;11(1).

15. Silver HM. Mechanism of increased maternal serum total activin A and
inhibinA in preeclampsia. J SocGynecolInvestig. 2002;9:308-12.

16. Heazell A, Baker PN. Hypertensive disorders of pregnancy. In: Oakley

C, Warnes CA, eds. Heart disease in pregnancy. 2nd ed.
Massachusetts: Blackwell Publishing; 2007:264-80.

17. Mustafa R, Ahmed S, Gupta A, Venuto RC. A comprehensive review of

hypertension in pregnancy. J Pregnancy 2012;2012:1-19.

18. Regitz-Zagrosek V, Blomstrom LC, Borghi C, Cifkova R, Ferreira R,

Foidart JM, et al. ESC guidelines on the management of cardiovascular
diseases during pregnancy: The task force on the management of
cardiovascular diseases during pregnancy of the European Society of
Cardiology (ESC). Eur Heart J. 2011;32:3147-97.

19. Dennis AT. Management of pre-eclampsia : Issues for anaesthetists.

Anaesthesia 2012;67:1009-20.

20. Podymow T, August P. Hypertension in pregnancy. In: Black HR, Elliott

WJ, eds. Hypertension: A companion to Braunwald’s heart disease.
2nd ed. Philadelphia: Elsevier Saunders; 2013:327– 35.

21. Badan POM RI. 2008. Informatorium Obat Nasional

Indonesia.Jakarta:CV Agung Seto.

22. Ganiswara, G. Sulistia, dkk. (edt), 2007, Farmakologi dan Terapi, Edisi
kelima, Jakarta: Bagian farmakologi FKUI.

23. Tim Editorial MIMS. 2016. MIMS Petujuk Konsultasi Edisi ke15. PT
Memidata. Jakarta.